Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19
2020; Korean Academy of Medical Sciences; Volume: 35; Issue: 13 Linguagem: Inglês
10.3346/jkms.2020.35.e142
ISSN1598-6357
AutoresEu Suk Kim, Bum Sik Chin, Chang Kyung Kang, Nam Joong Kim, Yu Min Kang, Jae‐Phil Choi, Dong Hyun Oh, Jeong-Han Kim, Bo Ram Koh, Seong Eun Kim, Na Ra Yun, Jae Hoon Lee, Jin Yong Kim, Yeonjae Kim, Ji Hwan Bang, Kyoung‐Ho Song, Hong Bin Kim, Ki-Hyun Chung, Myoung‐don Oh,
Tópico(s)Long-Term Effects of COVID-19
ResumoBackground: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019.In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea.Methods: All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide.Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness.Results: The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male.The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%).Diarrhea was not common (10.7%).Two patients had no symptoms.Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients.Six patients (21.4%) required
Referência(s)